Beyond the Prescription: How Ketamine-Assisted Therapy Is Reshaping Psychiatric Care
Ketamine used to be a word you only heard in an operating room. Today, it’s becoming one of the most talked-about tools in psychiatry — and for patients who’ve spent years cycling through medications that dull symptoms without ever touching the root of what’s wrong, it’s opening a door that traditional treatment often can’t.
Dr. Beverly Reader, a board-certified psychiatrist, has built her practice around a different question than the one most patients are used to being asked. Instead of starting with “which medication should we try next,” she starts with “what part of you is this symptom trying to protect?”
A Catalyst, Not a Cure
Ketamine-assisted psychotherapy pairs a carefully monitored, sub-anesthetic dose of ketamine with structured therapeutic support before, during, and after the session. The medication itself isn’t the treatment — it’s the catalyst. In the altered state it produces, the rigid defenses people build over a lifetime often soften, making it possible to access memories, emotions, and internal “parts” of themselves that stay just out of reach in a standard 15-minute med-check appointment.
“Most of psychiatry treats symptoms from the outside in,” Dr. Reader explains. “This work is about going the other direction — helping someone actually connect with the parts of themselves that are carrying the pain, instead of just quieting the noise.”
That spiritually-integrated, whole-person approach is a marked departure from the assembly-line feel many patients describe when they talk about psychiatric care. It’s slower, more intentional, and treats the mind-body connection as central to healing rather than incidental to it.
Who It’s For
Ketamine-assisted therapy has shown particular promise for treatment-resistant depression, anxiety, and trauma — conditions where conventional medication has plateaued or stopped working altogether. It is not a first-line treatment for everyone, and it isn’t a shortcut. Patients still do the work of therapy; the ketamine simply changes what’s accessible during that work.
For patients who’ve felt like they’ve “tried everything,” that shift in accessibility can be the difference between another year of managing symptoms and an actual breakthrough.
The Bigger Shift in Psychiatric Care
Dr. Reader’s practice is part of a broader movement of psychiatrists rethinking what the field owes its patients: not just symptom management, but a genuine path toward integration and self-understanding. As more research validates ketamine’s role in treatment-resistant cases, and as more clinicians pursue the specialized training this kind of work requires, patients are gaining access to an option that treats the whole person — not just the diagnosis on the chart.
This is a first-draft launch post pending Dr. Reader’s clinical review and sign-off before publishing.
